Cargando…
COVID‐19 hypothesis: Activated protein C for therapy of virus‐induced pathologic thromboinflammation
Seriously ill patients with coronavirus disease 2019 (COVID‐19) at risk for death exhibit elevated cytokine and chemokine levels and D‐dimer, and they often have comorbidities related to vascular dysfunctions. In preclinical studies, activated protein C (APC) provides negative feedback downregulatio...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292662/ https://www.ncbi.nlm.nih.gov/pubmed/32548551 http://dx.doi.org/10.1002/rth2.12362 |